FMP

FMP

Enter

GMDA - Gamida Cell Ltd.

photo-url-https://images.financialmodelingprep.com/symbol/GMDA.png

Gamida Cell Ltd.

GMDA

NASDAQ

Inactive Equity

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. In addition, the company is developing NK cell pipeline comprising GDA-301, GDA-401, GDA-501, and GDA-601 to treat hematologic malignancies and solid tumors. The company was founded in 1998 and is headquartered in Jerusalem, Israel.

0.0327 USD

-0.0073 (-22.32%)

GMDA Financial Statements

Year

2023

2022

2021

2020

Total Revenue

1.78M

0

0

0

Cost of Revenue

3.48M

440k

431k

357k

Gross Profit

-1.69M

-440k

-431k

-357k

Operating Expenses

70.95M

74.99M

87.17M

62.3M

Research and Development

22.28M

42.69M

50.18M

41.38M

Selling, General & Administrative Expenses

48.66M

19.4M

16.98M

12.17M

Selling & Marketing Expenses

4.08M

12.9k

20.01k

8.89k

General & Administrative Expenses

44.58M

19.4M

16.98M

12.17M

Other Expenses

-395k

12.9M

20.01M

8.75M

Operating Income

-72.64M

74.99M

-87.17M

-62.3M

Total Other Income/Expenses Net

9.65M

-4.38M

-2.63M

-648k

Income Before Tax

-63M

-79.38M

-89.79M

-72.7M

Income Tax

-1

74.99M

2.63M

3.74M

Net Income

-63M

-154.37M

-92.42M

-76.45M

Basic EPS

-0.57

-2.42

-1.56

-1.75

EPS Diluted

-0.57

-2.42

-1.56

-1.75

Basic Average Shares

110.05M

63.83M

59.25M

43.73M

Diluted Average Shares

110.05M

63.83M

59.25M

43.73M

EBITDA

-70.62M

-74.55M

-86.74M

-60.57M

All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep